Safety and Effectiveness of Liv.52 DS in Patients With Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study.

Saved in:
Bibliographic Details
Title: Safety and Effectiveness of Liv.52 DS in Patients With Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study.
Authors: Shivnitwar SK; General Medicine, D. Y. Patil Medical College, Pune, IND., Gilada I; Skin and Sexually Transmitted Diseases, Unison Medicare and Research Centre, Mumbai, IND., Rajkondawar AV; Internal Medicine, Government Medical College, Nagpur, Nagpur, IND., Ojha SK; Hyperbaric Medicine and Woundcare, Jayyush Hospital, Ahmedabad, IND., Katiyar S; Pulmonology Department, Apollo Spectra Hospital, Kanpur, IND., Arya N; Ayurveda, Sri Sai Institute of Ayurvedic Research and Medicine, Bhopal, IND., Babu UV; Research and Development, Himalaya Wellness Company, Bengaluru, IND., Kumawat R; Medical Services and Clinical Development, Himalaya Wellness Company, Bengaluru, IND.
Source: Cureus [Cureus] 2024 May 23; Vol. 16 (5), pp. e60898. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.60898